A booster dose of VLA15 is safe and induces substantial anamnestic immune responses against all six OspA serotypes. As with previously investigated OspA-based Lyme borreliosis vaccines, waning immune responses were observed with VLA15, and annual boost...
A booster dose of VLA15 is safe and induces substantial anamnestic immune responses against all six OspA serotypes. As with previously investigated OspA-based Lyme borreliosis vaccines, waning immune responses were observed with VLA15, and annual boost...
Ticks are on the move! Propelled northwards in the temperate climate zones of the northern hemisphere by increasingly conducive climates, ticks are bringing with them several disease-causing pathogens.1 Ticks are responsible for about 90% of all vector...
Ticks are on the move! Propelled northwards in the temperate climate zones of the northern hemisphere by increasingly conducive climates, ticks are bringing with them several disease-causing pathogens.1 Ticks are responsible for about 90% of all vector...
Dattwyler RJ, Arnaboldi PM. Vaccination hesistancy in Lyme borreliosis. Lancet Infect Dis 2024; published online May 31. https://doi.org/10.1016/S1473-3099(24)00221-4—In this Comment, the declaration of interests has been updated. This correction has b...
Our study highlighted the potential for reduced risk of mortality, ICU admission, or the need for ventilatory support in patients hospitalised with COVID-19 treated with nirmatrelvir–ritonavir as a monotherapy compared with treatment regimens based on ...
In The Lancet Infectious Diseases, Ming Hong Choi and colleagues1 evaluated the effectiveness of nirmatrelvir–ritonavir and remdesivir combination therapy with remdesivir monotherapy and nirmatrelvir–ritonavir monotherapy in hospitalised patients with ...
With its annual recurrence, influenza presents a substantial threat to global public health, causing millions of illnesses and thousands of deaths worldwide.1 Some populations, such as older adults, children younger than 5 years, pregnant people, and p...
With its annual recurrence, influenza presents a substantial threat to global public health, causing millions of illnesses and thousands of deaths worldwide.1 Some populations, such as older adults, children younger than 5 years, pregnant people, and p...
The H3N2 M2SR vaccine coadministered with Fluzone HD in older adults was well tolerated and provided enhanced immunogenicity compared with Fluzone HD administered alone, suggesting potential for improved efficacy of influenza vaccination in this age gr...
The H3N2 M2SR vaccine coadministered with Fluzone HD in older adults was well tolerated and provided enhanced immunogenicity compared with Fluzone HD administered alone, suggesting potential for improved efficacy of influenza vaccination in this age gr...
The avian influenza A(H5N1) virus was first identified in southern China in 1996, leading to substantial outbreaks among poultry in Hong Kong in 1997, which resulted in 18 human infections. Although the 1997 avian epidemic was controlled, the A(H5N1) v...
Searching for “COVID-19 lessons learned” on PubMed gives you 4840 results—a long list of opinion pieces, reviews, and consensus statements telling us what we can learn from our recent pandemic experience. At the same time, 138 dairy herds in the USA ha...
An outbreak of mpox due to a dangerous new subclade in DR Congo is causing international concern, yet no vaccine is available in the country. Alix Boisson-Walsh reports.
Paireau J, Guillot S, Aït El Belghiti F, et al. Effect of change in vaccine schedule on pertussis epidemiology in France: a modelling and serological study. Lancet Infect Dis 2022; 22: 265–73—The full appendix for this Article has now been supplied. Th...
Transplanting organs from cytomegalovirus-seropositive donors into cytomegalovirus-seronegative recipients is an accepted practice. However, outcomes following transplantation of organs from donors with active cytomegalovirus disease are unknown. We pr...